期刊文献+

四氮戊省磺酸钠对半乳糖性白内障防治及其醛糖还原酶抑制作用

Sodium 5,12-dihydro 5,7,12,14-azapentacene disulfonate alleviates galactose-induced cataract in rats and inhibits aldose raductase activity
原文传递
导出
摘要 目的:考察本实验室自制四氮戊省磺酸钠对半乳糖性白内障的防治效果及其对醛糖还原酶(AR)的抑制作用。方法:造大鼠半乳糖性白内障模型,同时给予高、低浓度药物滴眼液治疗,并以市售法可林滴眼液作阳性对照。观察大鼠白内障生成情况;检测各组大鼠晶状体中超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-PX)、过氧化氢酶(CAT)等活性和丙二醛(MDA)含量;用饱和硫酸铵盐析法提取牛晶状体中的AR,测定四氮戊省磺酸钠对其抑制作用。结果:在考察四氮戊省磺酸钠对大鼠半乳糖性白内障的影响实验中,药物治疗组大鼠的白内障发展情况缓慢于未给药的模型对照组,且高浓度组缓慢于低浓度组。药物能有效增强晶状体中SOD、GSH-PX、CAT活性(P<0.01,P<0.01,P<0.05),降低MDA含量(P<0.05)。同时四氮戊省磺酸钠对于醛糖还原酶具有良好的抑制作用。结论:四氮戊省磺酸钠对于大鼠半乳糖糖性白内障具有确切的防治作用,并对醛糖还原酶也具有良好的抑制作用。 Objective : To investigate the effects of sodium 5,12-dihydro 5,7,12,14-azapentacene disulfonate on galactose-induced cataract in rats and on the activity of aldose reductase (AR). Methods: Cataract was induced by galactose in rats, and treated by azapentacene disulfonate eye-drops at lower or higher concentration with commercial Phacolin as the control. The activities of superoxide dismutase (SOD) , glutathione peroxidase ( GSH- PX) and catalase (CAT) as well as malondialdehyde (MDA) content in the lens were measured. AR was extracted from bovine lens with saturated ammonium sulfate, and its inhibition by azapentacene disulfonate was determined. Results: After treatment with azapentacene disulfonate eye-drops, the lens opacities was attenuated, the activities of SOD, GSH-PX and CAT were significantly increased (P 〈 0.05 - 0.01 ) , and MDA content was reduced (P 〈 0.05) in rats with galactose-induced cataract. Aazapentaeene disulfonate also inhibited aldose reductase activity. Conclusion: The synthetic azapentacene disulfonate can delay and alleviate aglactose-induced cataract of rats, and can inhibit aldose reductase in bovine lens.
出处 《中国新药杂志》 CAS CSCD 北大核心 2009年第11期1027-1031,共5页 Chinese Journal of New Drugs
基金 山东省自然科学基金资助项目(Y2007B46)
关键词 四氮戊省磺酸钠 糖性白内障 醛糖还原酶 azapentacene disulfonate diabetic cataract aldose reductase
  • 相关文献

参考文献10

二级参考文献60

  • 1郝振海,闫明,刘冬玲,刘宁,刘庆艮,陈秀鑑.亚硒酸钠诱发大鼠白内障实验方法的改进[J].眼科新进展,1993,13(3):12-13. 被引量:18
  • 2庞贻慧 鲁纯素.药物稳定性预测方法的简化-初均速法[J].药学学报,1982,17(3):207-211.
  • 3黄秀榕 祁明信.锌在控制实验性半乳糖白内障中的作用[J].中华眼科杂志,1987,5(4):293-295.
  • 4广东省卫生厅.广东省药品标准 [S]: 1987年版:下册[M].,1 187..
  • 5国家药典委员会编.中华人民共国药典(二部) [S]: 2000年版[M].北京:化学工业出版社,2000.附录Ⅳ.
  • 6Ivers RQ, Cumming RG, Mitchell P, et al. Diabetes and risk of fracture: The blue mountains eye study [J]. Diabetes Care, 2001; 24(7):1198-1203.
  • 7Janghorbani MB, Jones RB, Allison SP. Incidence of and risk factors for cataract among diabetes clinic attenders [J]. Ophthalmic Epidemiol, 2000; 7(1):13-25.
  • 8Struck HG, Heider C, Lautenschlager C. Changes in the lens epithelium of diabetic and non-diabetic patients with various forms of opacities in senile cataract [J]. Klin Monatsbl Augenheilkd, 2000; 216(4):204-209.
  • 9Rowe NG, Mitchell PG, Cumming RG, et al. Diabetes, fasting blood glucose and age-related cataract: The blue mountains eye study [J]. Ophthalmic Epidemiol, 2000;7(2):103-114.
  • 10Matsumoto K, Ikeda K. Immunochemical evidence for increased formation of advanced glycation end products and inhibition by aminoguanidine in diabetic rat lenses [J]. Biochem Biophys Res Commun, 1997; 241(2):352-354.

共引文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部